Adagene Inc. (FRA:978)
Germany · Delayed Price · Currency is EUR 3.500
+0.040 (1.16%)
At close: Mar 27, 2026
Adagene Market Cap
Adagene has a market cap or net worth of €154.23 million as of March 27, 2026. Its market cap has increased by 92.12% in one year.
Market Cap
154.23M
Enterprise Value
105.64M
Revenue
87.88K
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.50
Market Cap Chart
Since February 9, 2021, Adagene's market cap has decreased from 1.05B to 154.23M, a decrease of -85.26%. That is a compound annual growth rate of -31.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 154.23M | 103.29% |
| Dec 31, 2025 | 75.87M | -10.84% |
| Dec 31, 2024 | 85.09M | 11.10% |
| Dec 29, 2023 | 76.59M | 42.27% |
| Dec 30, 2022 | 53.84M | -82.59% |
| Dec 31, 2021 | 309.16M | -70.44% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.44B |
| Darwin AG | 92.40M |
| 2invest AG | 62.87M |
| Biomark Diagnostics | 37.83M |
| co.don AG | 360.77K |
| bioXXmed AG | 323.52K |
| Paion AG | 232.56K |
| MagForce AG | 137.58K |